COVID-19 tied to elevated risk of benign prostatic hyperplasia complications

SARS-CoV-2 infection linked to increased benign prostatic hyperplasia (BPH) complications and medication use. Urological manifestations in COVID-19 patients emphasize the importance of awareness among clinicians.

Related Keywords

Hong Kong , ,Hong Kong Hospital Authority ,Internal Medicine ,Hong Kong Hospital ,Coronavirus Disease Covid 19 ,Prostate ,Ce2 ,Ngiotensin ,Ngiotensin Converting Enzyme 2 ,Benign Prostatic Hyperplasia ,Coronavirus ,Diabetes ,Diabetes Mellitus ,Nzyme ,Hematuria ,Hyperplasia ,Medicine ,Metabolic Syndrome ,Espiratory ,Cars ,Ars Cov 2 ,Serine ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,